Trademarkia Logo

Canada

C$
Trademark Search in Canada
INTRAVANT

View On IC.GC.CA

INTRAVANT
REGISTERED

on 21 Nov 2022

Last Applicant/ Owned by

ROIVANT SCIENCES GMBH

Viaduktstrasse 84051 Basel

CH

Serial Number

1941551 filed on 18th Jan 2019

Registration Number

TMA1152434 registered on 21st Nov 2022

Registration expiry Date

21st Nov 2032

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

INTRAVANT

Trademark usage description

pharmaceutical preparations for human use for the treatment of internal diseases, disorders and conditions, namely, anti-infectives, human immunodefic Read More

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment of internal diseases, disorders and conditions, namely, anti-infectives, human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicellazoster virus, Epstein-Barr virus and cytomegalovirus, respiratory diseases and disorders and their symptoms, immune system related diseases and disorders, namely, immunosuppressants, immunologic diseases and disorders, namely, autoimmune diseases and disorders, inflammation and inflammatory related diseases and disorders, namely, arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis, inflammatory connective tissue diseases and injuries, and tuberculosis; Allergy medications; Vaccines, namely, prophylactic and therapeutic vaccines for humans; biologic preparations for medical and therapeutic purposes for the treatment of internal diseases, disorders and conditions, namely, anti-infectives, human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicellazoster virus, Epstein-Barr virus and cytomegalovirus, respiratory diseases and disorders and their symptoms, immune system related diseases and disorders, namely, immunosuppressants, immunologic diseases and disorders, namely, autoimmune diseases and disorders, inflammation and inflammatory related diseases and disorders, namely, arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis, inflammatory connective tissue diseases and injuries, and tuberculosis.

Classification kind code

11

Class [042]
Scientific and technological services and research and design relating thereto namely, medical research, scientific research and analysis in the fields of internal diseases, disorders and conditions, pharmaceuticals, biomedicine, clinical trials and post-market trials; pharmaceutical, biomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials.

Classification kind code

11

Class [044]
Providing health and medical information in the fields of internal diseases, disorders and conditions, pharmaceuticals, biomedicine, clinical trials and post-market trials; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions.

Classification kind code

11

Mark Details

Serial Number

1941551

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 191
on 16th Nov 2022		Registration Fee Notice Sent
Submitted for opposition 42
on 24th Aug 2022		Advertised
Submitted for opposition 27
on 22nd Jul 2022		Approval Notice Sent
Submitted for opposition 26
on 22nd Jul 2022		Approved
Submitted for opposition 15
on 14th Jan 2022		Correspondence Created
Submitted for opposition 22
on 31st Aug 2021		Search Recorded
Submitted for opposition 20
on 31st Aug 2021		Examiner's First Report
Submitted for opposition 31
on 23rd Jan 2019		Formalized
Submitted for opposition 1
on 21st Jan 2019		Created
Submitted for opposition 30
on 18th Jan 2019		Filed